FDA authorises COVID-19 vaccines use as a booster dose

COVID-19 booster. Image: Cryptographer/Shutterstock.com

The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine.

These vaccines have been authorised for use as a single booster dose at least two months following primary or booster vaccination, the FDA confirmed on Wednesday, August 31.

The Moderna COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 18 years of age and older.

The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 12 years of age and older.

The monovalent COVID-19 vaccines that are authorized or approved by the FDA and have been administered to millions of people in the United States since December 2020 contain a component from the original strain of SARS-CoV-2.

FDA Commissioner Robert M. Califf, M.D., confirmed that: “The COVID-19 vaccines, including boosters, continue to save countless lives and prevent the most serious outcomes (hospitalization and death) of COVID-19,”

He added: “As we head into fall and begin to spend more time indoors, we strongly encourage anyone who is eligible to consider receiving a booster dose with a bivalent COVID-19 vaccine to provide better protection against currently circulating variants.”

Symptoms of coronavirus (COVID-19) in adults can include:

  • a high temperature or shivering (chills) – a high temperature means you feel hot to touch on your chest or back (you do not need to measure your temperature)
  • a new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours
  • a loss or change to your sense of smell or taste
  • shortness of breath
  • feeling tired or exhausted
  • an aching body
  • a headache
  • a sore throat
  • a blocked or runny nose
  • loss of appetite
  • diarrhoea
  • feeling sick or being sick

The symptoms are very similar to symptoms of other illnesses, such as colds and flu.


Thank you for taking the time to read this article, do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories and remember, you can also follow us on Facebook and Instagram.

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Anna Ellis

Originally from the UK, Anna is based on the Costa Blanca and is a web reporter for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at [email protected]

Comments


    • M

      03 September 2022 • 21:35

      Don’t know if they think people are either fools or fodder for another coctail, and to clarify these injections are not Vaccines, they have no long term safety trial data to be scrutinised well before a genuine License is approved.
      Omicron will move on to an even lower level and chances are people who had the first covid-19 injections still contract Omicron and pass this on freeley to others.
      The EU is still unwilling to publish the information contained in the contracts they signed with Big pharma last time, (you draw your own conclusions),so if an injection is offered to the people, then we the people DEMAND full transparency which could impact peoples lives. One last thought, are the risks of taking another untested covid injection with lack of long term safety data outweigh the Mild Omicron variant?

      Reply

    Leave a comment

    Your email address will not be published.